• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Lithium citrate tribasic tetrahydrate

CAS No. 6080-58-6

Lithium citrate tribasic tetrahydrate ( —— )

产品货号. M15283 CAS No. 6080-58-6

Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease.

纯度: >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
50MG ¥292 有现货
100MG ¥381 有现货
200MG ¥551 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Lithium citrate tribasic tetrahydrate
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease.
  • 产品描述
    Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease. Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model. Lithium Citrate has been reported to use as a mood stabilizer when treating bipolar mood disorders (BD) and reduce the risk of self-harm in BD patient. In addition, Lithium Citrate has been found to be the choice drug in treatment of acute manic episodes. Moreover, Lithium Citrate has been revealed to dissolve uric acid crystals in urine obtained from patients with gout. Besides, Lithium Citrate has been exhibited to have some dose-dependent side-effects. The most of the side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which leading to the accumulation of PAP.
  • 同义词
    ——
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    Dehydrogenase
  • 受体
    IMPDH; mGluR3; GSK-3β
  • 研究领域
    Other Indications
  • 适应症
    ——

化学信息

  • CAS Number
    6080-58-6
  • 分子量
    281.98
  • 分子式
    C6H13Li3O11
  • 纯度
    >98%(HPLC)
  • 溶解度
    Soluble in DMSO
  • SMILES
    [Li].[Li].[Li].O.O.O.O.OC(=O)CC(O)(CC(O)=O)C(O)=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Oruch R, et al. Eur J Pharmacol. 2014 Jun 30. pii: S0014-2999(14)00493-2
产品手册
关联产品
  • CAY10566

    CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.

  • Teriflunomide

    Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis.

  • PfDHODH-IN-2

    PfDHODH-IN-2 is a dihydrothiophenone derivative, is a potent Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH, IC50 : 1.11 μM) inhibitor.